Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IES Holdings (IESC) Cash & Equivalents (2016 - 2025)

IES Holdings' Cash & Equivalents history spans 16 years, with the latest figure at $88.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 50.38% year-over-year to $88.8 million, compared with a TTM value of $88.8 million through Dec 2025, up 50.38%, and an annual FY2025 reading of $127.2 million, up 26.12% over the prior year.
  • Cash & Equivalents for Q4 2025 was $88.8 million at IES Holdings, down from $127.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $127.2 million in Q3 2025, with the low at $5.2 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $50.5 million, with a median of $33.0 million recorded in 2021.
  • Year-over-year, Cash & Equivalents soared 1567.42% in 2023 and then plummeted 78.84% in 2025.
  • Tracing IESC's Cash & Equivalents over 5 years: stood at $7.8 million in 2021, then plummeted by 32.98% to $5.2 million in 2022, then soared by 1567.42% to $87.5 million in 2023, then tumbled by 32.45% to $59.1 million in 2024, then surged by 50.38% to $88.8 million in 2025.
  • Per Business Quant, the three most recent readings for IESC's Cash & Equivalents are $88.8 million (Q4 2025), $127.2 million (Q3 2025), and $101.4 million (Q2 2025).